A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

Inclusion Criteria: * Male 20 year ≤ age ≤ 40 year. * Weight ≥ 55kg, IBW ±20%. * Patients with normal hematology, biochemistry, urinary result. * Patients who have not congenital or chronic disease. * Provision of written informed consent voluntarily. Exclusion Criteria: * Patients having known hypersensitivity to any component of the study drug. * Patients with a history of abnormal digestive organ, kidney, respiratory, neuroendocrine, cardiovascular, hemato-oncology, urinary, muscloskeletal, immune, the nose and ears, psychiatry, stomach system. * Patients with any gastrointestinal disorders. * Systolic blood pressure ≥ 150 or ≤ 90 mmHg, Diasolic blood pressure ≥ 95 or ≤ 50 mmHg. * Drug abuser, alcoholic. * Patients taking ETC medication within 14 days, OTC within 7 days. * Patients taking other investigational product within 60 days prior to the participation in the study.